Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Zhonghong Biopharmaceutical Institute is a research-driven biotechnology company and technical service provider based in the Nanjing Jiangbei New Area, China. Founded by experts in clinical pharmacology and pharmacogenetics, the institute specializes in the R&D of innovative drugs and the consistency evaluation of high-end generic medications. The organization provides comprehensive services including pharmacokinetic (PK) and pharmacodynamic (PD) analysis, bioequivalence (BE) studies, and precision medicine solutions. It operates as a key translational platform, bridging the gap between laboratory discovery and clinical application through advanced analytical technologies and regulatory expertise. The institute is particularly recognized for its leadership in drug metabolism research and its role in supporting the regional biopharmaceutical ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Zhonghong Biopharmaceutical Institute.